STOCK TITAN

Freedom Hldg Inc - FHLD STOCK NEWS

Welcome to our dedicated news page for Freedom Hldg (Ticker: FHLD), a resource for investors and traders seeking the latest updates and insights on Freedom Hldg.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Freedom Hldg's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Freedom Hldg's position in the market.

Rhea-AI Summary
Freedom Holdings, Inc. (FHLD) receives notice from FINRA that they have completed the Form 211 review. The company plans to gain QB status on the OTC Markets board and is in negotiations with companies in the cannabis industry for a potential merger. CEO Vivian expresses gratitude to Glendale Securities for their support.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Freedom Holdings, Inc. announces new business objectives including a cannabis space merger and plans to increase operations and assets. The company aims to capture a percentage of the $57.18 billion cannabis marketplace. Freedom Holdings will present at an emerging growth virtual conference on March 6, 2024, to discuss business efforts and achievements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Freedom Holdings, Inc. (FHLD) is awaiting final approval of its 15c211 from FINRA, which will allow the company to explore additional funding opportunities. The company is also in talks with institutions and investors for potential investments. Freedom Holdings plans to purchase a new facility for cannabis product extraction, manufacturing, and testing. The medical cannabis division expects to begin FDA clinical trials to treat cancer pain in mid-February, giving the company a clear advantage for early completion. Despite challenges, the company's ability to adapt and pivot in evolving markets sets it apart.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.25%
Tags
none
Rhea-AI Summary
Freedom Holdings, Inc. (OTC PINK:FHLD) has engaged a firm to complete its 15c211 application, bringing the company audit, regulatory filings, and disclosure up to date. The company is now 'PINK CURRENT' on OTC Markets and plans to be listed as QB on the OTC Markets board. They are also looking to acquire and merge other cannabis companies under their umbrella.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.96%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.96%
Tags
none
Freedom Hldg Inc

OTC:FHLD

FHLD Rankings

FHLD Stock Data

6.19M
6.98M
88.96%
Mortgage and Nonmortgage Loan Brokers
Finance and Insurance
United States
Ossian